Ballaho, Noridzna Shanaia M.
HRN: 25-18-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 750MG (VIAL)
10/25/2024
11/01/2024
IV
350mg
Q 8 Hours
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes